Close

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more

REPLAGAL® (agalsidase alfa)

This product is registered in numerous countries throughout the world. If information relevant to your country is not available on this page, please consult your local physician.

This product is licensed in the following countries:

Argentina (local website)
Australia (local website)
Austria
Belgium
Brazil
Bulgaria
Canada (local website)
Croatia
Cyprus
Czech Republic
Denmark (local website)
Estonia
Finland
France (local website)  
Germany (local website)
Greece
Hungary
Iceland
Ireland (local website)
Israel
Italy (local website)
Japan
Latvia
Lichtenstein
Lithuania
Luxembourg
Malta
Mexico
Netherlands (local website)
New Zealand
Norway
Paraguay
Poland
Portugal
Romania
Russia
Slovakia
Slovenia
Spain (local website)
Sweden
Switzerland (local website)
Taiwan
Turkey
United Kingdom (local website)
Uruguay

Our global reach

Our products are marketed in over 50 countries worldwide, and we now have offices in 29 countries. View our interactive map, and learn more
about our global reach.

Our locations